H3 Biomedicine
Show Menu
About
About Us
Our Team
Our Story
An Eisai Company
Our Culture
Science
Scientific Approach
Pipeline
Scientific Publications
Partnering
Patients
Diseases We Study
Clinical Trials
Resources
Investigational Medication
Media Relations
Press Releases
In the News
Company Information
Careers
Opportunities
Benefits
Metabolic Disposition of H3B-8800, an Orally Available Small-Molecule Splicing Modulator, in Rats, Monkeys, and Humans
Seeking Additional Information?
Contact